Skip to main content
Veterinary Medicines

PORCILIS APP vet injektioneste, suspensio

Authorised
  • Actinobacillus pleuropneumoniae, outer membrane protein
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid

Product identification

Medicine name:
PORCILIS APP vet injektioneste, suspensio
Active substance:
  • Actinobacillus pleuropneumoniae, outer membrane protein
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, outer membrane protein
    50.00
    unit(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, APX III toxoid
    50.00
    unit(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, APX II toxoid
    50.00
    unit(s)
    /
    1.00
    Dose
  • Actinobacillus pleuropneumoniae, APX I toxoid
    50.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 13558
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 6/09/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 6/09/2024